nach oben

Acta Neurologica Belgica

Erschienen in:

20.09.2023 | Original article

Clinical and laboratory findings and etiologies of genetic homocystinemia: a single-center experience

verfasst von: Seyda Besen, Yasemin Ozkale, Serdar Ceylaner, Aytul Noyan, Ilknur Erol

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Homocysteine (Hcy) is an endogenous nonprotein sulfur-containing amino acid biosynthesized from methionine by the removal of its terminal methyl group. Hyperhomocysteinemia (HHcy) has been linked to many systemic disorders, including stroke, proteinuria, epilepsy, psychosis, diabetes, lung disease, and liver disease. The clinical effects of high serum Hcy level, also known as hyperhomocysteinemia, have been explained by different mechanisms. However, little has been reported on the clinical and laboratory findings and etiologies of genetic HHcy in children. This study aimed to examine the relationships between clinical features, laboratory findings, and genetic defects of HHcy.

Methods

We retrospectively evaluated 20 consecutive children and adolescents with inherited HHcy at the pediatric neurology division of Baskent University, Adana Hospital (Adana, Turkey) between December 2011 and December 2022.

Results

Our main finding is that the most common cause of genetic HHcy is MTHFR mutation. The other main finding is that the Hcy level was higher in patients with CBS deficiency and intracellular cbl defects than in MTHFR mutations. We also found that clinical presentations of genetic HHcy vary widely, and the most common clinical finding is seizures. Here, we report the first and only case of a cbl defect with nonepileptic myoclonus. We also observed that mild and intermediate HHcy associated with the MTHFR mutation may be related to migraine, vertigo, tension-type headache, and idiopathic intracranial hypertension. Although some of the patients were followed up in tertiary care centers for a long time, they were not diagnosed with HHcy. Therefore, we suggest evaluating Hcy levels in children with unexplained neurological symptoms.

Conclusions

Our findings suggest that genetic HHcy might be associated with different clinical manifestations and etiologies. Therefore, we suggest evaluating Hcy levels in children with unexplained neurologic symptoms.

Zaric BL, Obradovic M, Bajic V, Haidara MA, Jovanovic M, Isenovic ER (2019) Homocysteine and hyperhomocysteinaemia. Curr Med Chem 26(16):2948–2961. https://doi.org/10.2174/0929867325666180313105949CrossRefPubMed

Graham IM, Daly LE, Refsum HM et al (1997) Plasma homocysteine as a risk factor for vascular disease. Eur Concerted Action Project JAMA 277(22):1775–1781. https://doi.org/10.1001/jama.1997.03540460039030CrossRef

Coban-Karatas M, Erol I, Ozkale Y, Yazıcı N (2013) Central retinal artery occlusion in a 13-year-old child as a presenting sign of hyperhomocysteinemia together with high lipoprotein(a) level. Pediatr Neurol 49(2):138–140. https://doi.org/10.1016/j.pediatrneurol.2013.04.002CrossRefPubMed

Thurtell MJ, Bruce BB, Newman NJ, Biousse V (2010). An update on idiopathic intracranial hypertension. Rev Neurol Dis; 7(2–3):e56–68. PMID: 20944524; PMCID: PMC3674489

Muttamthottil Varghese Francis. Brief migraine episodes in children and adolescents-a modification to International Headache Society pediatric migraine (without aura) diagnostic criteria. Springerplus. 2(1):77. https://doi.org/10.1186/2193-1801-2-77

Stern LL, Bagley PJ, Rosenberg IH (2000) Conversion of 5-formyltetrahydrofolic acid is unimpaired in folate-adequate persons homozygous for the C677T mutation in the methylenetetrahydrofolate reductase gene. J Nutr 130(9):2238–2242. https://doi.org/10.1093/jn/130.9.2238CrossRefPubMed

Lopaciuk S, Bykowska K, Kwiecinski H et al (2001) Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolat reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 7(4):346–350. https://doi.org/10.1177/107602960100700418CrossRefPubMed

Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J (1997) A common polymorphism in the methylenetetrahydrofolat reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 28(9):1739–1743. https://doi.org/10.1161/01.str.28.9.1739CrossRefPubMed

Ho PI, Collins SC, Dhitavat S et al (2001) Homocysteine potentiatesbeta-amyloid neurotoxicity: role of oxidative stres. J Neurochem 78(2):249–253. https://doi.org/10.1046/j.1471-4159.2001.00384.xCrossRefPubMed

10.

Homberger G, Linnebank M, Winter C (2000) Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur J Hum Genet 8(9):725–729. https://doi.org/10.1038/sj.ejhg.5200522CrossRefPubMed

11.

Ono H, Sakamoto A, Mizoguchi N, Sakura N (2002) The C677Tmutation in the methylenetetrahydrofolate reductase gene contributesto hyperhomocysteinemia in patients taking anticonvulsants. Brain Dev 24(4):223–226. https://doi.org/10.1016/s0387-7604(02)00004-9CrossRefPubMed

12.

Prasad AN, Rupar CA, Prasad C (2011) Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy. Brain Dev 33(9):758–769. https://doi.org/10.1016/j.braindev.2011.05.014CrossRefPubMed

13.

Van der Put NM, Gabreels F, Stevens EM et al (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62(5):1044–1O51 https://doi.org/10.1086/301825.

14.

Molloy AM, Daly S, Mills JL et al (1997) Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349(9065):1591–1593. https://doi.org/10.1016/S0140-6736(96)12049-3CrossRefPubMed

15.

Van der Put NM, Steegers-Theunissen RP, Frosst P et al (1995) Mutated methylenetetrahydro folate reductase as a risk factor for spina bifida. Lancet 346(8982):1070–10711. https://doi.org/10.1016/s0140-6736(95)91743-8CrossRefPubMed

16.

Vurucu S, Demirkaya E, Kul M et al (2008) Evaluation of the relationship between C677T variants of methylenetetrahydro folate reductase gene and hyperhomocysteinemiain children receiving antiepileptic drug therapy. Prog Neuro- Psychopharmacol Biol Psychiatry 32(3):844–848. https://doi.org/10.1016/j.pnpbp.2007.12.018CrossRef

17.

Wu YL, Yang HY, Ding XX et al (2014) Association between methylene tetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis. Seizure 23(6):411–416. https://doi.org/10.1016/j.seizure.2014.01.018CrossRefPubMed

18.

Lipton SA, Kim WK, Choi YB et al (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 94(11):5923–5928. https://doi.org/10.1073/pnas.94.11.5923ADSCrossRefPubMedPubMedCentral

19.

Rai V, Kumar P (2018) Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy. Neurol Sci 39(12):2033–2041. https://doi.org/10.1007/s10072-018-3583-zCrossRefPubMed

20.

Liew SC, Gupta ED (2015) Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet 58(1):1–10. https://doi.org/10.1016/j.ejmg.2014.10.004CrossRefPubMed

21.

Karabiber H, Sonmezgoz E, Ozerol E, Yakinci C, Otlu B, Yologlu S (2003) Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev 25(2):113–115. https://doi.org/10.1016/s0387-7604(02)00163-8CrossRefPubMed

22.

Fu Y, Wang X, Kong W (2018) Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets. Br J Pharmacol 58(1):1–10. https://doi.org/10.1016/j.ejmg.2014.10.004CrossRef

23.

Lee EJ, Cho YJ, Yoon YJ (2010) Methylenetetrahydrofolate reductase C677T gene mutation as risk factor for sudden sensorineural hearing loss: association with plasma homocysteine, folate and cholesterol concentrations. J Laryngol Otol 124(12):1268–1273. https://doi.org/10.1017/S002221511000099XCrossRefPubMed

24.

Scaramella JG (2003) Hyperhomocysteinemia and left internal jugular vein thrombosis with Ménière’s symptom complex. Ear Nose Throat J 82(11):856CrossRefPubMed

25.

Weiss N (2005) Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr Drug Metab 6(1):27–36. https://doi.org/10.2174/1389200052997357CrossRefPubMed

26.

De Bruijn SF, de Haan RJ, Stam J (2001) Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients for the cerebral venous sinus thrombosis study group. J Neurol Neurosurg Psychiatry 70(1):105–108. https://doi.org/10.1136/jnnp.70.1.105CrossRefPubMedPubMedCentral

27.

Yetgin S, Derman O, Dogan M (2006) A pediatric patient with recurrent pseudotumor cerebri and vitamin b12 deficiency. Pediatr Hematol Oncol 23(1):39–43. https://doi.org/10.1080/08880010500313322CrossRefPubMed

28.

Kara I, Sazci A, Ergul E, Kaya G, Kilic G (2003) Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 111(1–2):84–90. https://doi.org/10.1016/s0169-328x(02)00672-1CrossRefPubMed

29.

Rainero I, Vacca A, Roveta F, Govone F, Gai A, Rubino E (2019) Targeting MTHFR for the treatment of migraines. Expert Opin Ther Targets 23(1):29–37. https://doi.org/10.1080/14728222.2019.1549544CrossRefPubMed

30.

Yeganeh F, Nikbakht F, Bahmanpour S, Rastegar K, Namavar RJ (2013) Neuroprotective effects of NMDA and group I metabotropic glutamate receptor antagonists against neurodegeneration induced by homocysteine in rat hippocampus: in vivo study. Mol Neurosci 50(3):551–557. https://doi.org/10.1007/s12031-013-9996-5CrossRef

31.

Lossos A, Teltsh O, Milman T et al (2014) Severe methylenetetrahydrofolate reductase deficiency: clinical clues to a potentially treatable cause of adult-onset hereditary spastic paraplegia. JAMA Neurol 71(7):901–4. https://doi.org/10.1001/jamaneurol.2014CrossRefPubMed

32.

Marelli C, Lavigne C, Stepien KM et al (2021) Clinical and molecular characterization of adult patients with late-onset MTHFR deficiency. J Inherit Metab Dis 44(3):777–786. https://doi.org/10.1002/jimd.12323CrossRefPubMed

33.

Bottiglieri T, Parnetti L, Arning E et al (2001) Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia. Mech Ageing Dev 122(16):2013–2023. https://doi.org/10.1016/s0047-6374(01)00307-4CrossRefPubMed

34.

Altun H, Şahin N, Belge Kurutaş E, Güngör O (2018) Homocysteine, pyridoxine, folate and vitamin B12 levels in children with attention deficit hyperactivity disorder. Psychiatr Danub 30(3):310–316. https://doi.org/10.24869/psyd.2018.310CrossRefPubMed

35.

Pavone V, Praticò AD, Parano E, Pavone P, Verrotti A, Falsaperla R (2012) Spine and brain malformations in a patient obligate carrier of MTHFR with autism and mental retardation. Clin Neurol Neurosurg 114(9):1280–1282. https://doi.org/10.1016/j.clineuro.2012.03.008CrossRefPubMed

36.

Huemer M, Diodato D, Martinelli D et al (2019) Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: data from the E-HOD registry. J Inherit Metab Dis 42(2):333–352. https://doi.org/10.1002/jimd.12041CrossRefPubMed

37.

Huemer M, Diodato D, Schwahn B et al (2017) Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis 40(1):21–48. https://doi.org/10.1007/s10545-016-9991-4CrossRefPubMed

38.

Li DX, Li XY, Dong H et al (2018) Eight novel mutations of CBS gene in nine Chinese patients with classical homocystinuria. World J Pediatr 14(2):197–203. https://doi.org/10.1007/s12519-018-0135-9MathSciNetCrossRefPubMed

39.

Huemer M, Kožich V, Rinaldo P et al (2015) Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines. J Inherit Metab Dis 38(6):1007–1019. https://doi.org/10.1007/s10545-015-9830-zCrossRefPubMedPubMedCentral

Titel: Clinical and laboratory findings and etiologies of genetic homocystinemia: a single-center experience
verfasst von: Seyda Besen
Yasemin Ozkale
Serdar Ceylaner
Aytul Noyan
Ilknur Erol
Publikationsdatum: 20.09.2023
Verlag: Springer International Publishing
Erschienen in: Acta Neurologica Belgica / Ausgabe 1/2024
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-023-02356-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

The effects of rehabilitative interventions on reading disorders caused by homonymous visual field defects: a meta-analysis focusing on improvement in reading speed

Towards a neurocognitive profile in familial cerebral cavernous malformations

Correspondence on COVID-19 vaccination uptake in people with multiple sclerosis

Comparing infusion-related reactions of the first full dose (600 mg) biosimilar ocrelizumab administration with the standard divided protocol in multiple sclerosis patients: a randomized controlled trial study

PLWH treated with modern ART and high CD4 T cell counts: no evidence of HIV-associated vasculopathy measured by extra- and intracranial ultrasound